Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Giner Inc. has 4 pending office actions in the Chemistry & Materials technology area. These actions are distributed among 4 distinct examiners and 4 distinct art units, indicating a broad technical scope for their current prosecution. The involvement of 4 distinct art units suggests that the company's chemical innovations are being evaluated by multiple specialized groups within the patent office. This distribution means the company must navigate the requirements of four separate art units, each with its own set of examination standards and timelines.
ELLABIB, MAAP AHMED is the busiest examiner for the company, currently managing 1 pending office action. With 4 pending office actions in total and 4 distinct examiners involved, the workload is spread such that each examiner is responsible for exactly one matter. This lack of examiner concentration means that prosecution strategies must be tailored to the specific tendencies of four different individuals across four separate art units. The presence of 4 distinct examiners highlights the need for a versatile approach to the company's Chemistry & Materials portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| Multi-statute (no §101) | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ELLABIB, MAAP AHMED | 1 | 64.0% | +37.3% |
| MARTIN, ANGELA J | 1 | 67.3% | -31.4% |
| SCHLOOP, ALLISON ELIZABETH | 1 | 63.3% | +47.6% |
| ALABI, OYELEYE A | 1 | 83.9% | +23.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17887347 | METHOD AND SYSTEM FOR DETECTING ONE OR MORE DRUGS AND/OR DRUG METABOLITES IN WASTEWATER | ALABI, OYELEYE A | 78d overdue |
| 18574203 | OXYGEN DELIVERY AND RECLAMATION SYSTEM | ELLABIB, MAAP AHMED | — |
| 18286863 | ELECTROLYTES OF RECHARGEABLE LITHIUM-SULFUR BATTERIES AND LITHIUM-SULFUR BATTERIES INCLUDING THE SAME | MARTIN, ANGELA J | — |
| 18295613 | METHOD AND SYSTEM FOR DETECTING FUNGAL GENES AND KIT FOR USE WITH SAME | SCHLOOP, ALLISON ELIZABETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17887347 | METHOD AND SYSTEM FOR DETECTING ONE OR MORE DRUGS AND/OR DRUG METABOLITES IN WASTEWATER | ALABI, OYELEYE A | 78d overdue |
| 18574203 | OXYGEN DELIVERY AND RECLAMATION SYSTEM | ELLABIB, MAAP AHMED | — |
| 18295613 | METHOD AND SYSTEM FOR DETECTING FUNGAL GENES AND KIT FOR USE WITH SAME | SCHLOOP, ALLISON ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 3785 | 1 |
| 1727 | 1 |
| 1683 | 1 |
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18574203 | OXYGEN DELIVERY AND RECLAMATION SYSTEM | ELLABIB, MAAP AHMED | 3785 | §102§103 | Non-Final OA | — | Pending | Dec 26, 2023 |
| 18286863 | ELECTROLYTES OF RECHARGEABLE LITHIUM-SULFUR BATTERIES AND LITHIUM-SULFUR BATTERIES INCLUDING THE SAME | MARTIN, ANGELA J | 1727 | §102§103 | Non-Final OA | — | Pending | Oct 13, 2023 |
| 18295613 | METHOD AND SYSTEM FOR DETECTING FUNGAL GENES AND KIT FOR USE WITH SAME | SCHLOOP, ALLISON ELIZABETH | 1683 | §101§103§112 | Non-Final OA | — | Pending | Apr 04, 2023 |
| 17887347 | METHOD AND SYSTEM FOR DETECTING ONE OR MORE DRUGS AND/OR DRUG METABOLITES IN WASTEWATER | ALABI, OYELEYE A | 1797 | §102§103 | Final Rejection | 78d overdue | Pending | Aug 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGiner Inc. has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Maap Ahmed Ellabib has the most, with 1 of Giner Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
